Vendor Intelligence Report: Yidan Biotech

Published 2 Jul 2026. 16-page investigative report on who is behind Yidan Biotech: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Across 8 Finnrick lab tests, Yidan Biotech records 6 pass / 2 fail — an overall pass rate of 75%, with Retatrutide and Tirzepatide both reading as cautious-use rather than clean-repeat GLP-1…